56 results match your criteria: "The Barts Heart Centre[Affiliation]"
J Interv Card Electrophysiol
August 2024
Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
Background And Aims: Catheter ablation is superior to pharmacological therapy in controlling atrial fibrillation (AF). There are few data on the long-term outcome of AF ablation in octogenarian patients. This analysis aims to evaluate the outcome of AF ablation in octogenarians vs.
View Article and Find Full Text PDFEuropace
November 2023
The Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS trust, W Smithfield, EC1A 7BE London, UK.
Aims: Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation for atrial fibrillation (AF). There are limited data on the PolarX Cryoballoon. The study aimed to establish the safety, efficacy, and feasibility of same day discharge for Cryoballoon PVI.
View Article and Find Full Text PDFCirc Arrhythm Electrophysiol
September 2023
National Heart and Lung Institute, Imperial College London, United Kingdom (A. Sau, S.K., J.H., M.B.S., A.A., D.B.K., N.S.P., F.S.N.).
Background: Ablation for persistent atrial fibrillation (PsAF) has been performed for over 20 years, although success rates have remained modest. Several adjunctive lesion sets have been studied but none have become standard of practice. We sought to describe how the efficacy of ablation for PsAF has evolved in this time period with a focus on the effect of adjunctive ablation strategies.
View Article and Find Full Text PDFEuropace
May 2023
The Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS trust, West Smithfield, London WC1 8BE, UK.
Aims: Arrhythmogenic right ventricular cardiomyopathy (ARVC) patients develop ventricular arrhythmias (VAs) responsive to anti-tachycardia pacing (ATP). However, VA episodes have not been characterized in accordance with the device therapy, and with the emergence of the subcutaneous implantable cardioverter defibrillator (S-ICD), the appropriate device prescription in ARVC remains unclear. Study aim was to characterize VA events in ARVC patients during follow-up in accordance with device therapy and elicit if certain parameters are predictive of specific VA events.
View Article and Find Full Text PDFInt J Environ Res Public Health
February 2023
Istituto Auxologico Italiano, IRCCS, Department of Cardiology, Piazzale Brescia 20, 20149 Milan, Italy.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiac disease associated with an increased risk of life-threatening arrhythmias. The aim of the present study was to evaluate the association of ventricular arrhythmias (VA) with circadian and seasonal variation in ARVC. One hundred two ARVC patients with an implantable cardioverter defibrillator (ICD) were enrolled in the study.
View Article and Find Full Text PDFJ Cardiovasc Electrophysiol
May 2023
The Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
Neurol Genet
October 2022
Clinical Pharmacology Group (D.K.R., D.G.), Pharmacy and Medicines Directorate, St George's University Hospitals NHS Foundation Trust; Clinical Pharmacology and Therapeutics Section (D.K.R., D.G.), Institute of Medical and Biomedical Education and Institute for Infection and Immunity, St George's, University of London; Centre for Clinical Pharmacology and Therapeutics (D.K.R.), University College London; Department of Epidemiology and Biostatistics (V.K., B.S., I.T., D.G.), School of Public Health, Imperial College London, United Kingdom; Research Unit of Mathematical Sciences (V.K.), University of Oulu; Center for Life Course Health Research (V.K.), University of Oulu, Finland; Clinical Pharmacology (M.T.), William Harvey Research Institute, Queen Mary University of London; The Barts Heart Centre and NIHR Barts Biomedical Research Centre-Barts Health NHS Trust (M.T.), The William Harvey Research Institute, Queen Mary University London; Novo Nordisk Research Centre Oxford (M.T., T.G.R., D.G.), Old Road Campus, Oxford; Medical Research Council Integrative Epidemiology Unit (T.G.R.), University of Bristol; Medical Research Council Biostatistics Unit (S.B., D.G.), Cambridge Institute of Public Health; Cardiovascular Epidemiology Unit (S.B.), Department of Public Health and Primary Care, University of Cambridge, United Kingdom; and Department of Hygiene and Epidemiology (I.T.), University of Ioannina, Greece.
J Cardiovasc Electrophysiol
October 2022
The Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
Introduction: Markers predicting atrial fibrillation (AF) termination and freedom from AF/atrial tachycardia (AT) has been proposed. This study aimed to evaluate the role of novel coronary sinus (CS) electrogram characteristics in predicting the acute ablation response and freedom from AF/AT during follow-up.
Methods: Patients undergoing ablation for persistent AF as part of the Stochastic Trajectory Analysis of Ranked signals mapping study were included.
Europace
October 2022
The Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, W. Smithfield, EC1A 7BE London, UK.
Aim: Evaluate the novel PolarX Cryoballoon in atrial fibrillation (AF) catheter ablation through a propensity-matched comparison with the Arctic Front Advance (AFA). The aim was also to identify cryoablation metrics that are predictive of successful pulmonary vein isolation (PVI) with the PolarX Cryoballoon.
Methods And Results: This prospective multi-centre study included patients that underwent cryoablation for AF.
Rev Cardiovasc Med
December 2021
School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Components of carotid atherosclerotic plaque can be analysed preoperatively by non-invasive advanced imaging modalities such as magnetic resonance imaging (MRI). The expression of matrix metalloproteinase-9 protein (MMP-9), which has a potential role in remodelling of atherosclerotic plaques, can be analysed immunohistochemically. The aim of the present prospective pilot study is to analyse histological characteristics and expression of MMP-9 in carotid plaques of patients undergoing carotid endarterectomy (CEA) and to investigate the correlation with preoperative clinical symptoms and MRI features.
View Article and Find Full Text PDFNeurology
January 2022
From Clinical Pharmacology (V.T.-B., P.M., M.T.), William Harvey Research Institute, Queen Mary University of London; Department of Epidemiology and Biostatistics (D.P.), School of Public Health, and Department of Medicine (D.G.), Centre for Pharmacology and Therapeutics, Imperial College London; Novo Nordisk Research Centre (D.G., M.T.), Oxford; Clinical Pharmacology and Therapeutics Section (D.G.), Institute of Medical and Biomedical Education and Institute for Infection and Immunity, St. George's, University of London; Clinical Pharmacology Group (D.G.), Pharmacy and Medicines Directorate, St. George's University Hospitals NHS Foundation Trust, London, UK; Institute for Stroke and Dementia Research (M.G., R.M.), University Hospital of Ludwig-Maximilians-University, Munich, Germany; National Institute for Health Research Barts Cardiovascular Biomedical Research Centre (P.M.), Queen Mary University of London; The Barts Heart Centre and NIHR Barts Biomedical Research Centre-Barts Health NHS Trust (M.T.), William Harvey Research Institute, Queen Mary University London, UK; Center for Genomic Medicine (M.K.G.), Massachusetts General Hospital, Boston; and Program in Medical and Population Genetics (M.K.G.), Broad Institute of Harvard and the Massachusetts Institute of Technology, Boston.
Background And Objectives: Cardiovascular risk factors have been implicated in the etiology of cerebral small vessel disease (CSVD); however, whether the associations are causal remains unclear in part due to the susceptibility of observational studies to reverse causation and confounding. Here, we use mendelian randomization (MR) to determine which cardiovascular risk factors are likely to be involved in the etiology of CSVD.
Methods: We used data from large-scale genome-wide association studies of European ancestry to identify genetic proxies for blood pressure, blood lipids, body mass index (BMI), type 2 diabetes, smoking initiation, cigarettes per day, and alcohol consumption.
Brain
October 2021
Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich, Germany.
White matter hyperintensities (WMH) are among the most common radiological abnormalities in the ageing population and an established risk factor for stroke and dementia. While common variant association studies have revealed multiple genetic loci with an influence on their volume, the contribution of rare variants to the WMH burden in the general population remains largely unexplored. We conducted a comprehensive analysis of this burden in the UK Biobank using publicly available whole-exome sequencing data (n up to 17 830) and found a splice-site variant in GBE1, encoding 1,4-alpha-glucan branching enzyme 1, to be associated with lower white matter burden on an exome-wide level [c.
View Article and Find Full Text PDFBrain
March 2022
Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Age-related loss of white matter microstructural integrity is a major determinant of cognitive decline, dementia and gait disorders. However, the mechanisms and molecular pathways that contribute to this loss of integrity remain elusive. We performed a genome-wide association study of white matter microstructural integrity as quantified by diffusion MRI metrics (mean diffusivity and fractional anisotropy) in up to 31 128 individuals from UK Biobank (age 45-81 years) based on a two degrees of freedom (2df) test of single nucleotide polymorphism (SNP) and SNP × Age effects.
View Article and Find Full Text PDFJ Card Surg
September 2021
Department of Cardiology, Gloucester Royal Hospital, Gloucester, UK.
Background And Aim Of The Study: A subtle aortic dissection can be challenging to detect despite the availability of multiple diagnostic modalities. Whilst rare, the inability to detect this variant of aortic dissection can lead to a dismal prognosis. We present an extremely rare case of a subtle aortic dissection with supra-annular aortic root intimal tear and acute severe aortic regurgitation in a patient with a bicuspid aortic valve.
View Article and Find Full Text PDFHeart
July 2021
Institute of Cardiovascular Sciences, University College London, London, UK.
Lancet Neurol
May 2021
Clinical Neurosciences, University of Cambridge, Cambridge, UK. Electronic address:
JACC Clin Electrophysiol
February 2021
The Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom. Electronic address:
Objectives: The goal of this study was to develop a risk score model for patients with Brugada syndrome (BrS).
Background: Risk stratification in BrS is a significant challenge due to the low event rates and conflicting evidence.
Methods: A multicenter international cohort of patients with BrS and no previous cardiac arrest was used to evaluate the role of 16 proposed clinical or electrocardiogram (ECG) markers in predicting ventricular arrhythmias (VAs)/sudden cardiac death (SCD) during follow-up.
Ann Cardiothorac Surg
May 2020
Clinical Lead for Cardiac Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK.
Interv Cardiol
November 2019
Interventional Cardiologist and TAVI Operator at the Barts Heart Centre, St Bartholomew's Hospital, London. He trained at Manchester University, St Bartholomew's Hospital, the London Chest Hospital and St Vincent's Hospital, Melbourne. His research interests relate to aortic valve and coronary interventions.
Europace
March 2020
Department of Arrhythmia Services, The Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Aims: Although cryoballoon pulmonary vein isolation is a well-established treatment for paroxysmal atrial fibrillation (AF), it's role in persistent AF is unclear. We examined procedural success and long-term outcomes of cryoablation in persistent and longstanding persistent AF.
Methods And Results: International multicentre registry from three UK and eight European centres.
BMC Cardiovasc Disord
October 2019
Institute of Cardiovascular Science, University College London, 222 Euston Road, London, NW1 2DA, UK.
Background: We characterised the phenotypic consequence of genetic variation at the PCSK9 locus and compared findings with recent trials of pharmacological inhibitors of PCSK9.
Methods: Published and individual participant level data (300,000+ participants) were combined to construct a weighted PCSK9 gene-centric score (GS). Seventeen randomized placebo controlled PCSK9 inhibitor trials were included, providing data on 79,578 participants.
Eur Heart J
August 2020
The Barts Heart Centre, Barts Health NHS Trust, Department of Arrhythmia Management, London, UK.
J Cardiovasc Electrophysiol
December 2019
Electrophysiology department, The Barts Heart Centre, London, United Kingdom.
Introduction: The optimal way to map localized drivers in persistent atrial fibrillation (AF) remains unclear. The objective of the study was to apply a novel vector mapping approach called Stochastic Trajectory Analysis of Ranked signals (STAR) in AF.
Methods And Results: Patients having persistent AF ablation were included.
Clin Case Rep
May 2019
Department of Cardiac Electrophysiology The Barts Heart Centre, St Bartholomew's Hospital London UK.
All clinicians prescribing amiodarone require knowledge of the challenging diagnosis and management of amiodarone-induced pulmonary toxicity (APT), which is potentially fatal. APT should be considered early in all patients presenting with new respiratory symptoms and concurrent amiodarone therapy. Drug cessation and corticosteroid therapy can be highly effective once recognized.
View Article and Find Full Text PDFInterv Cardiol
February 2019
Interventional Cardiologist and TAVI Operator at the Barts Heart Centre, St Bartholomew's Hospital, London. He trained at Manchester University, St Bartholomew's Hospital, the London Chest Hospital and St Vincent's Hospital, Melbourne. His research interests relate to aortic valve and coronary interventions.